Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2015, Willamette Valley Capital (WVC) is based in the United States and specializes in early-stage investments. The firm focuses on deep-tech companies led by capable teams, providing both capital and coaching to prepare startups for growth. WVC sources deals from various U.S. regions, including Oregon, Arizona, California, New York, and Vermont, emphasizing thorough technical and business diligence.
WVC invests in early-stage deep-tech companies across sectors such as healthcare, climate, and frontier technologies. The firm targets regions with significant research and development but limited capital, aiming to support startups that tackle critical issues like healthcare innovation and environmental performance. Typical investment stages include pre-seed, seed, and seed+ (extension).
WVC's portfolio features notable companies such as Agility Robotics, which develops agile robotic mobility platforms; Blaze Bioscience, focused on improving cancer surgery visualization; and Cartogram, offering hospital navigation software. Other investments include Cascade ProDrug, CytoImage, Diatomix, Dune Sciences, eChemion, Elucid, and Hemex Health.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.